<DOC>
<DOCNO>
EP-0015772
</DOCNO>
<TEXT>
<DATE>
19800917
</DATE>
<IPC-CLASSIFICATIONS>
C07D-501/24 C07D-239/00 C07D-521/00 C07D-501/00 C07D-239/36 
</IPC-CLASSIFICATIONS>
<TITLE>
n-(2-((acylaminoacylamino or aminoacylamino)phenyl)-4-hydroxy-5-pyrimidinylcarbonyl)cephalosporin compounds, processes for their production, and compositions containing the same.
</TITLE>
<APPLICANT>
warner lambert cous<sep>warner-lambert company<sep>warner-lambert company201 tabor roadmorris plains new jersey 07950us<sep>
</APPLICANT>
<INVENTOR>
haskell theodore herbertus<sep>mich thomas frederick us<sep>sanchez joseph peter us  <sep>schweiss dietrichus<sep>haskell, theodore herbert<sep>mich, thomas frederick<sep>sanchez, joseph peter<sep>schweiss, dietrich<sep>haskell, theodore herbert3860 loch alphine drive w.ann arbor michigan 48103us<sep>mich, thomas frederick915 sunset roadann arbor michigan 48103us<sep>sanchez, joseph peter739 meadowlake roadcanton michigan 48188us<sep>schweiss, dietrich7136 plymouth roadann arbor michigan 48105us<sep>
</INVENTOR>
<ABSTRACT>
n-[2-[(acylaminoacylamino or aminoacylamino)­ phenyl]-4-hydroxy-5-pyrimidinylcarbonyl] cephalosporin  compounds having the formula    showing broad spectrum antibacterial utility are provided,  which may be produced by (a) reacting the free amino acid  of the appropriate cephalosporin or the acid salt or silylated  derivative or complex thereof with a reactive derivative of  the corresponding n-2-[(acylaminoacylamino or aminoacyl­ amino)phenyl]-4-hydroxy-5-pyrimidine carboxylic acid or  (b) reacting the free amino acid 7-aminocephalosporanic  acid or a related compound or the acid salt or silylated  derivative thereof with a reactive derivative of the corres­ ponding d-n-[1-[(acylaminoacylamino or aminoacyl­ amino)phenyl]-4-hydroxy- 5-pyrimldinylcarbonyl]-2-substi­ tuted glycine.  pharmaceutical compositions containing  these compounds and methods for treating infections using  such compositions are also disclosed.  
</ABSTRACT>
</TEXT>
</DOC>
